LABORATORY CORP OF AMERICA HOLDINGS
8-K, 1998-07-07
MEDICAL LABORATORIES
Previous: LABORATORY CORP OF AMERICA HOLDINGS, 8-K, 1998-07-07
Next: LABORATORY CORP OF AMERICA HOLDINGS, 8-K, 1998-07-07






      UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C. 20549

                          FORM 8-K
                              
                       CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934

                        JUNE 12, 1998
                        -------------
              (Date of earliest event reported)

                              
         LABORATORY CORPORATION OF AMERICA HOLDINGS
         ------------------------------------------
   (Exact name of registrant as specified in its charter)
                              
                              
      DELAWARE              1-11353             13-3757370
      --------              -------             ----------   
  (State or other         (Commission         (IRS Employer
  jurisdiction of         File Number)        Identification
  incorporation)                              Number)


   358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
   -------------------------------------------------------
          (Address of principal executive offices)
                              
                        336-229-1127
                        ------------
    (Registrant's telephone number, including area code)

<PAGE>
<PAGE>

ITEM 5. OTHER EVENTS

On June 12, 1998, the Company issued a press release
announcing that its Board of Directors has declared
dividends on the Company's 8 1/2% Series A Convertible
Exchangeable Preferred Stock and the Company's 8 1/2% Series
B Convertible Pay-in-Kind Preferred Stock.

ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
        INFORMATION AND EXHIBITS

 (c)  Exhibit
      20  Press release of the Company dated June 12, 1998.

<PAGE>
<PAGE>

                         SIGNATURES

Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned
hereunto duly authorized.

               LABORATORY CORPORATION OF AMERICA HOLDINGS
               ------------------------------------------    
                              (Registrant)

                    By:/s/ BRADFORD T. SMITH
                       ------------------------------
                           Bradford T. Smith
                           Executive Vice President,
                           General Counsel, Secretary
                           and Compliance Officer



Date: July 7, 1998
<PAGE>
<PAGE>




FOR IMMEDIATE RELEASE    CONTACT:             PAMELA SHERRY
- ---------------------                         336-584-5171, EXT. 4855


                         SHAREHOLDER DIRECT:  800-LAB-0401
                                              WWW.LABCORP.COM


        LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK-DECLARES
                           PREFERRED STOCK DIVIDENDS


BURLINGTON, NC, JUNE 12, 1998 - Laboratory Corporation of America-Registered
Trademark-Holdings (LabCorp-Registered Trademark-) (NYSE: LH) today announced
that its Board of Directors has declared a dividend of $1.0625 per share on
the Company's 8 1/2 % Series A Convertible Exchangeable Preferred Stock
(Series A Preferred Stock), payable in cash.  The Board has also declared a
dividend of $1.0625 per share on the Company's 8 1/2 % Series B Convertible
Pay-in-Kind Preferred Stock (Series B Preferred Stock), payable in shares of
Series B Preferred Stock at the rate of 0.02125 shares per share of Series B
Preferred Stock held.  No fractional shares of Series B Preferred Stock will
be issued, so that the number of shares to be paid as a dividend on the Series
B Preferred Stock will be rounded to the nearest whole number of shares.  The
dividends will be payable on June 30, 1998 for each issued and outstanding
share of Series A and B Preferred Stock to stockholders of record on June 24,
1998, and will cover the dividend period from April 1, 1998 to June 30, 1998
at an equivalent annualized rate of $4.25 per share.

Laboratory Corporation of America-Registered Trademark-Holdings (LabCorp-
Registered Trademark-) is a national clinical laboratory organization with
annual revenues of $1.5 billion in 1997.  The Company operates primary testing
facilities nationally, offering more than 1,700 different clinical assays,
from routine blood analyses to more sophisticated technologies.  LabCorp
performs diagnostic tests for physicians, managed-care organizations,
hospitals, clinics, long-term care facilities, industrial companies and other
clinical laboratories.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission